Evidence map›Paper›PMID 27352904›Full record

ArticleScientific reports2016

Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategy.

Oleg G Chepurny, Colin A Leech, Martin Tomanik, Maria C DiPoto, Hui Li, Xinping Han, Qinghe Meng, Robert N Cooney, Jimmy Wu, George G Holz

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Frontiers in pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oleg G ChepurnyDepartment of Medicine, State University of New York (SUNY), Upstate Medical University, Syracuse, New York, USA.
Colin A LeechDepartment of Medicine, State University of New York (SUNY), Upstate Medical University, Syracuse, New York, USA.
Martin TomanikDepartment of Chemistry, Dartmouth College, Hanover, New Hampshire, USA.
Maria C DiPotoDepartment of Chemistry, Dartmouth College, Hanover, New Hampshire, USA.
Hui LiDepartment of Chemistry, Dartmouth College, Hanover, New Hampshire, USA.
Xinping HanDepartment of Chemistry, Dartmouth College, Hanover, New Hampshire, USA.
Qinghe MengDepartment of Surgery, State University of New York (SUNY), Upstate Medical University, Syracuse, New York, USA.
Robert N CooneyDepartment of Surgery, State University of New York (SUNY), Upstate Medical University, Syracuse, New York, USA.
Jimmy WuDepartment of Chemistry, Dartmouth College, Hanover, New Hampshire, USA.
George G HolzDepartment of Medicine, State University of New York (SUNY), Upstate Medical University, Syracuse, New York, USA.

Funding

Molecular Basis of Antidiabetogenic Hormone ActionR01DK069575 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI HOLZ, GEORGE G · 2007 to 2017
$2.9M
Synthesis and Target Identification of Potent GLP1 SecretagoguesR01GM111638 · NIGMS · DARTMOUTH COLLEGE · PI WU, JIMMY · 2014 to 2018
$1.5M
NIDDK NIH HHS R01 DK069575NIGMS NIH HHS R01 GM111638
6 · The paper itself

Abstract

Rational assembly of small molecule libraries for purposes of drug discovery requires an efficient approach in which the synthesis of bioactive compounds is enabled so that numerous structurally related compounds of a similar basic formulation can be derived. Here, we describe (4 + 3) and (3 + 2) indole annulation strategies that quickly generate complex indole heterocycle libraries that contain novel cyclohepta- and cyclopenta[b]indoles, respectively. Screening of one such library comprised of these indoles identifies JWU-A021 to be an especially potent stimulator of glucagon-like peptide-1 (GLP-1) secretion in vitro. Surprisingly, JWU-A021 is also a potent stimulator of Ca(2+) influx through TRPA1 cation channels (EC50 ca. 200 nM), thereby explaining its ability to stimulate GLP-1 release. Of additional importance, the available evidence indicates that JWU-A021 is one of the most potent non-electrophilic TRPA-1 channel agonists yet to be reported in the literature.

Indexed as

AnimalsCalcium SignalingDrug Evaluation, PreclinicalEnteroendocrine CellsGlucagon-Like Peptide 1HEK293 CellsHumansIndolesMiceStereoisomerismTRPA1 Cation ChannelGlucagon-Like Peptide 1IndolesTRPA1 Cation Channel

Identifiers

PMID27352904
PMCPMC4926213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.